Therese M.-L. Andersson
Karolinska Institutet
CancerRelative survivalPopulationDiabetes mellitusMedicine
What is this?
Publications 121
#1Kou Kou (QUT: Queensland University of Technology)H-Index: 2
#2Paramita Dasgupta (Cancer Council Queensland)H-Index: 8
Last. Peter D. Baade (Griffith University)H-Index: 44
view all 6 authors...
Abstract Background Loss of life expectancy (LOLE) provides valuable insights into the impact of cancer. We evaluated the temporal trends in LOLE for Australian cancer patients and the gain in life years for recently diagnosed patients due to survival improvements. Methods Analysis was conducted using an Australian population-based cohort (n = 1,865,154) aged 50–89 years, who were primarily diagnosed with one of 19 leading cancers between 1982–2015. Flexible parametric survival models were used ...
#1T. Wasterlid (KI: Karolinska Institutet)H-Index: 1
#2Sara Harrysson (KI: Karolinska Institutet)
Last. Karin E. Smedby (KI: Karolinska Institutet)H-Index: 47
view all 9 authors...
PURPOSE: Patients with diffuse large B-cell lymphoma (DLBCL) who fail to complete planned treatment with R-CHOP due to toxicity are sparsely described. We investigated the extent of failure to complete treatment (6 cycles or more, or 3 cycles + RT for patients with stage I disease) with R-CHOP for reasons unrelated to non-response, the determinants of such failure and the outcome among these patients. METHODS & RESULTS: 3149 adult DLBCL patients who started primary treatment with R-CHOP were ide...
#1Maximilian Zoltek (KI: Karolinska Institutet)
#2Therese M.-L. Andersson (KI: Karolinska Institutet)H-Index: 27
Last. Caroline Nordenvall (KI: Karolinska Institutet)H-Index: 13
view all 5 authors...
Introduction To minimize recurrence risk in differentiated thyroid cancer (DTC), TSH is usually lifelong suppressed with levothyroxine. A common consequence of this treatment is subclinical hyperthyroidism which can induce cardiovascular disease (CV). This study’s aim was to compare CV incidence in DTC patients with the general population in Sweden.
#1Malin Hultcrantz (KI: Karolinska Institutet)H-Index: 12
#2A. Ravn Landtblom (KI: Karolinska Institutet)
Last. Therese M.-L. Andersson (KI: Karolinska Institutet)H-Index: 27
view all 8 authors...
#1Erin E. Gabriel (KI: Karolinska Institutet)H-Index: 12
#2Michael C. Sachs (KI: Karolinska Institutet)H-Index: 21
Last. Therese M.-L. Andersson (KI: Karolinska Institutet)H-Index: 27
view all 4 authors...
Background: Little attention has been given to the risk of cardiovascular and psychiatric comorbidities during the clinical evaluation of a suspected hematological malignancy.Methods: Based on Skane Healthcare Register, we performed a population-based cohort study of 1,527,449 individuals residing during 2005-2014 in Skane, Sweden. We calculated the incidence rate ratios (IRRs) of cardiovascular diseases or psychiatric disorders during the diagnostic workup of 5495 patients with hematological ma...
The risk of suicide is elevated among patients with treatment-resistant depression (TRD). Risk factors for suicide and suicide attempts among cases and controls with TRD were investigated using dat...
#1Melina Arnold (IARC: International Agency for Research on Cancer)H-Index: 17
#2Mark J. Rutherford (IARC: International Agency for Research on Cancer)H-Index: 11
Last. Freddie Ian Bray (IARC: International Agency for Research on Cancer)H-Index: 88
view all 38 authors...
Summary Background Population-based cancer survival estimates provide valuable insights into the effectiveness of cancer services and can reflect the prospects of cure. As part of the second phase of the International Cancer Benchmarking Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provide a comprehensive overview of cancer survival across seven high-income countries and a comparative assessment of corresponding incidence and mortality trends. Met...
12 CitationsSource
#1Therese M.-L. Andersson (KI: Karolinska Institutet)H-Index: 27
#2Mark J. Rutherford (University of Leicester)H-Index: 11
Last. Paul C. Lambert (KI: Karolinska Institutet)H-Index: 44
view all 3 authors...
Background The life expectancy of cancer patients, and the loss in expectation of life as compared to the life expectancy without cancer, is a useful measure of cancer patient survival and complement the more commonly reported 5-year survival. The estimation of life expectancy and loss in expectation of life generally requires extrapolation of the survival function, since the follow-up is not long enough for the survival function to reach 0. We have previously shown that the survival of the canc...
#1Hannah Bower (KI: Karolinska Institutet)H-Index: 4
#2Michael J. Crowther (KI: Karolinska Institutet)H-Index: 19
Last. Paul C. Lambert (KI: Karolinska Institutet)H-Index: 44
view all 8 authors...
AbstractNon-proportional hazards are common within time-to-event data and can be modeled using restricted cubic splines in flexible parametric survival models. This simulation study assesses the ab...
1 CitationsSource